US2010188069A1PendingUtilityA1

Sensors using high electron mobility transistors

43
Assignee: REN FANPriority: Sep 18, 2007Filed: Mar 15, 2010Published: Jul 29, 2010
Est. expirySep 18, 2027(~1.2 yrs left)· nominal 20-yr term from priority
H10D 62/8503H10D 30/4755G01N 33/0045G01N 27/4145G01N 33/54306
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Embodiments of the invention include sensors comprising high electron mobility transistors (HEMTs) with capture reagents on a gate region of the HEMTs. Example sensors include HEMTs with a thin gold layer on the gate region and bound antibodies; a thin gold layer on the gate region and chelating agents; a non-native gate dielectric on the gate region; and nanorods of a non-native dielectric with an immobilized enzyme on the gate region. Embodiments including antibodies or enzymes can have the antibodies or enzymes bound to the Au-gate via a binding group. Other embodiments of the invention are methods of using the sensors for detecting breast cancer, prostate cancer, kidney injury, glucose, metals or pH where a signal is generated by the HEMT when a solution is contacted with the sensor. The solution can be blood, saliva, urine, breath condensate, or any solution suspected of containing any specific analyte for the sensor.

Claims

exact text as granted — not AI-modified
1 . An AlGaN/GaN high electron mobility transistor (HEMT) based sensor for one or more target molecules in a sample, the sensor comprising:
 an AlGaN/GaN high electron mobility transistor (HEMT); and   at least one capture reagent on a gate region of the AlGaN/GaN HEMT.   
   
   
       2 . The sensor of  claim 1 , further comprising at least one wireless communication circuit on a chip, wherein the AlGaN/GaN HEMT comprises an array of HEMTs on the chip, and wherein a signal from the sensor is wirelessly transmittable. 
   
   
       3 . The sensor of  claim 1 , wherein the AlGaN/GaN HEMT comprises an Au-comprising gate, and wherein the capture reagent binds or otherwise associates with a breast cancer antigen. 
   
   
       4 . The sensor of  claim 3 , wherein the capture reagent is an antibody to a breast cancer antigen selected from EGF, c-erbB-2, CA15-3, and any combination thereof. 
   
   
       5 . The sensor of  claim 3 , further comprising a binding group layer to couple the capture reagent to the Au-comprising gate. 
   
   
       6 . The sensor of  claim 3 , wherein the binding group layer comprises thioglycolic acid. 
   
   
       7 . The sensor of  claim 3 , further comprising a control HEMT connected to a source region of the AlGaN/GaN HEMT, wherein the control HEMT includes the Au-comprising gate and a protective layer covering the Au-comprising gate. 
   
   
       8 . The sensor of  claim 1 , wherein the AlGaN/GaN HEMT comprises an Au-comprising gate, the sensor comprising at least one chelating agent as a capture reagent. 
   
   
       9 . The sensor of  claim 8 , comprising at least one chelating agent selected from the group consisting of thioglycolic acid (HSCH 2 COOH), cysteamine (NH 2 CH 2 CH 2 SH), 1,2-ethanedithiol (HSCH 2 CH 2 SH), dimercaprol (BAL), diaminoethanetetraacetic acid (EDTA), 2,3-bis-sulfanylbutanedioic acid (DMSA), and 2,3-dimercapto-1-propanesulfonic acid (DMPS). 
   
   
       10 . The sensor of  claim 8 , further comprising a control HEMT connected to a source region of the AlGaN/GaN HEMT, wherein the control HEMT includes the Au-comprising gate and a protective layer covering the Au-comprising gate. 
   
   
       11 . The sensor of  claim 1 , comprising a gate dielectric as a capture reagent for detecting hydronium ion. 
   
   
       12 . The sensor of  claim 11 , wherein the gate dielectric comprises a non-native metal oxide. 
   
   
       13 . The sensor of  claim 12 , wherein the metal oxide comprises at least one of Sc 2 O 3 , Al 2 O 3 , TiO 2 , MgO, In 2 O 3 , SnO 2 , ZnO, and ZnMgO. 
   
   
       14 . The sensor of  claim 11 , further comprising a control HEMT connected to a source region of the AlGaN/GaN HEMT, wherein the control HEMT includes the gate dielectric and a protective layer covering the gate dielectric. 
   
   
       15 . The sensor of  claim 1 , wherein the AlGaN/GaN HEMT comprises an Au-comprising gate, and wherein the capture reagent comprises an antibody to kidney injury molecule-1 (KIM-1). 
   
   
       16 . The sensor of  claim 15 , further comprising a binding group layer to couple the antibody to the Au-comprising gate. 
   
   
       17 . The sensor of  claim 16 , wherein the binding group layer comprises thioglycolic acid. 
   
   
       18 . The sensor of  claim 15 , further comprising a control HEMT connected to a source region of the AlGaN/GaN HEMT, wherein the control HEMT includes the Au-comprising gate and a protective layer covering the Au-comprising gate. 
   
   
       19 . The sensor of  claim 1 , wherein the AlGaN/GaN HEMT comprises an Au-comprising gate, and wherein the capture reagent comprises a PSA antibody. 
   
   
       20 . The sensor of  claim 19 , further comprising a binding group layer to couple the PSA antibody to the Au-comprising gate. 
   
   
       21 . The sensor of  claim 20 , wherein the binding group layer comprises thioglycolic acid. 
   
   
       22 . The sensor of  claim 19 , further comprising a control HEMT connected to a source region of the AlGaN/GaN HEMT, wherein the control HEMT includes the Au-comprising gate and a protective layer covering the Au-comprising gate. 
   
   
       23 . The sensor of  claim 1 , comprising a gate dielectric layer comprising nanorods on the gate region, and glucose oxidase immobilized on the nanorods as the capture reagent. 
   
   
       24 . The sensor of  claim 23 , wherein the nanorods comprise a metal oxide. 
   
   
       25 . The sensor of  claim 24 , wherein the metal oxide comprises at least one of Sc 2 O 3 , Al 2 O 3 , TiO 2 , MgO, In 2 O 3 , SnO 2 , ZnO, and ZnMgO. 
   
   
       26 . The sensor of  claim 23 , further comprising a control HEMT connected to a source region of the at least one AlGaN/GaN HEMT, wherein the control HEMT includes the gate dielectric layer comprising the nanorods and a protective layer covering the Au-comprising gate. 
   
   
       27 . A method of detecting a target molecule in a sample comprising the steps of:
 providing a sample suspected of containing a target molecule; and   contacting the sample with a sensor comprising an AlGaN/GaN high electron mobility transistor (HEMT) and at least one capture reagent on a gate region of the AlGaN/GaN HEMT, wherein a signal is generated by the sensor when the target molecule is present in the sample and interacts with the capture reagent.   
   
   
       28 . The method of  claim 27 , wherein the sensor further comprises at least one wireless communication circuit on a chip, wherein the HEMT comprises an array of HEMTs on a chip, and wherein the signal is wirelessly transmittable. 
   
   
       29 . The method of  claim 28 , further comprising the step of transmitting wirelessly the signal to a receiver for the signal. 
   
   
       30 . The method of  claim 27 , wherein the sample is saliva, the target molecule is a breast cancer antigen, the HEMT comprises an Au-comprising gate, and the capture reagent is an antibody to the breast cancer antigen. 
   
   
       31 . The method of  claim 30 , wherein the sensor further comprises a binding agent layer to couple the antibody to the Au-comprising gate. 
   
   
       32 . The method of  claim 31 , wherein the binding group layer comprises thioglycolic acid. 
   
   
       33 . The method of  claim 27 , wherein the sample is aqueous, the target molecule is a metal, the HEMT comprises an Au-comprising gate, and the capture reagent comprises a chelating agent. 
   
   
       34 . The method of  claim 33 , wherein the metal is selected from the group consisting of Hg 2+ , Cu + 2, and Pb 2+  ion. 
   
   
       35 . The method of  claim 27 , wherein the sample is exhaled breath condensate, the target molecule is hydronium ion, and the HEMT comprises a gate dielectric that functions as a capture reagent. 
   
   
       36 . The sensor of  claim 35 , wherein the gate dielectric comprises a non-native metal oxide. 
   
   
       37 . The sensor of  claim 36 , wherein the non-native metal oxide comprises at least one of Sc 2 O 3 , Al 2 O 3 , TiO 2 , MgO, In 2 O 3 , SnO 2 , ZnO, and ZnMgO. 
   
   
       38 . The method of  claim 27 , wherein the sample is aqueous, the target molecule is kidney injury molecule-1(KIM-1), the HEMT comprises an Au-comprising gate, and the capture reagent comprises a KIM-1 antibody. 
   
   
       39 . The method of  claim 38 , wherein the sensor further comprises a binding group acid layer to couple the KIM-1 antibody to the Au-comprising gate. 
   
   
       40 . The method of  claim 39 , wherein the binding group layer comprises thioglycolic acid. 
   
   
       41 . The method of  claim 27 , wherein the sample is aqueous, the target molecule is prostate specific antigen (PSA), the HEMT comprises an Au-comprising gate, and the capture reagent comprises a PSA antibody. 
   
   
       42 . The method of  claim 41 , wherein the sensor further comprises a binding group layer to couple the PSA antibody to the Au-comprising gate. 
   
   
       43 . The method of  claim 42 , wherein the binding group layer comprises thioglycolic acid. 
   
   
       44 . The method of  claim 27 , wherein the sample is exhaled breath condensate, the target molecule is glucose, the HEMT comprises a gate dielectric layer comprising nanorods, and the capture reagent comprises glucose oxidase immobilized on the nanorods. 
   
   
       45 . The method of  claim 44 , wherein the nanorods comprise a metal oxide. 
   
   
       46 . The method of  claim 44 , wherein the metal oxide comprises at least one of ZnO, SnO, TiO 2 , MgO, ZnMgO, and In 2 O 3 . 
   
   
       47 . The method of  claim 27 , wherein the sample is exhaled breath condensate, saliva, urine, blood, other biological fluids, or other aqueous solutions. 
   
   
       48 . A high electron mobility transistor (HEMT) based sensor for one or more target molecules in a sample, comprising:
 an HEMT having a two layer structure of group semiconductor materials, the first layer of the two layer structure being a layer having a first ionic strength and the second layer of the two layer structure being a strained layer on the first layer and having a second ionic strength different than the first ionic strength, where a high density electron sheet carrier concentration channel of a 2-dimensional gas channel is induced by piezoelectric polarization of the strained layer and spontaneous polarization of the different ionic strengths between the second layer and the strained layer; and   at least one capture reagent on a gate region of the HEMT.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.